On the public citation graph
Costunolide attenuates high‐fat diet‐induced inflammation and oxidative stress in non‐alcoholic fatty liver disease
0 signed · 46 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.28421openalex-snapshot
Paracrine activation of hepatic stellate cells in platelet‐derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/ptr.7383openalex-snapshot
Costunolide protects against alcohol‐induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitro
inferredcites →https://doi.org/10.1007/s00011-019-01273-5openalex-snapshot
The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms
inferredcites →https://doi.org/10.1007/s00018-018-2947-0openalex-snapshot
Molecular pathways of nonalcoholic fatty liver disease development and progression
inferredcites →https://doi.org/10.1007/s10620-016-4049-xopenalex-snapshot
Innate Immunity and Inflammation in NAFLD/NASH
inferredcites →https://doi.org/10.1016/j.apsb.2022.09.014openalex-snapshot
Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases
inferredcites →https://doi.org/10.1016/j.bbadis.2018.06.023openalex-snapshot
Animal models of NAFLD from a hepatologist's point of view
inferredcites →https://doi.org/10.1016/j.bbrc.2019.01.104openalex-snapshot
Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-β1/Smad2/Nrf2-NOX4 signaling pathways
inferredcites →https://doi.org/10.1016/j.bcp.2017.04.014openalex-snapshot
Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2019.06.019openalex-snapshot
Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2020.02.025openalex-snapshot
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.intimp.2018.06.017openalex-snapshot
Costunolide ameliorates lipoteichoic acid-induced acute lung injury via attenuating MAPK signaling pathway
inferredcites →https://doi.org/10.1016/j.intimp.2020.106567openalex-snapshot
Costunolide improved dextran sulfate sodium-induced acute ulcerative colitis in mice through NF-κB, STAT1/3, and Akt signaling pathways
inferredcites →https://doi.org/10.1016/j.jhep.2018.10.033openalex-snapshot
Non-alcoholic fatty liver disease – A global public health perspective
inferredcites →https://doi.org/10.1016/j.jhep.2021.11.009openalex-snapshot
A new perspective on NAFLD: Focusing on lipid droplets
inferredcites →https://doi.org/10.1016/j.jnutbio.2016.10.012openalex-snapshot
Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model
inferredcites →https://doi.org/10.1016/s0140-6736(20)32511-3openalex-snapshot
Non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1021/acschembio.6b00651openalex-snapshot
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
inferredcites →https://doi.org/10.1038/nature01137openalex-snapshot
A central role for JNK in obesity and insulin resistance
inferredcites →https://doi.org/10.1038/ni1464openalex-snapshot
PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit
inferredcites →https://doi.org/10.1038/s41575-018-0009-6openalex-snapshot
Triggering and resolution of inflammation in NASH
inferredcites →https://doi.org/10.1038/s41591-018-0104-9openalex-snapshot
Mechanisms of NAFLD development and therapeutic strategies
inferredcites →https://doi.org/10.1053/j.gastro.2005.05.041openalex-snapshot
Natural History of NAFLD: Remarkably Benign in the Absence of Cirrhosis
inferredcites →https://doi.org/10.1080/08923973.2017.1327965openalex-snapshot
Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1080/17461391.2019.1571114openalex-snapshot
Mechanisms of beneficial effects of exercise training on non‐alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation
inferredcites →https://doi.org/10.1093/jpp/rgab032openalex-snapshot
Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats
inferredcites →https://doi.org/10.1111/bph.14873openalex-snapshot
Costunolide represses hepatic fibrosis through WW domain‐containing protein 2‐mediated Notch3 degradation
inferredcites →https://doi.org/10.1111/bph.14938openalex-snapshot
Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice
inferredcites →https://doi.org/10.1111/dom.14322openalex-snapshot
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
inferredcites →https://doi.org/10.1186/s12916-017-0806-8openalex-snapshot
Non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1248/yakushi.19-00011-3openalex-snapshot
Role of Angiogenesis and Chronic Inflammation in Fat Hypertrophy in NASH Pathology
inferredcites →https://doi.org/10.3389/fphar.2021.796207openalex-snapshot
Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.3390/antiox10020174openalex-snapshot
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
inferredcites →https://doi.org/10.3390/ijms20122926openalex-snapshot
Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
inferredcites →https://doi.org/10.3390/molecules25122840openalex-snapshot
Costunolide Plays an Anti-Neuroinflammation Role in Lipopolysaccharide-Induced BV2 Microglial Activation by Targeting Cyclin-Dependent Kinase 2
inferredcites →https://doi.org/10.3748/wjg.v24.i25.2661openalex-snapshot
Apoptosis and non-alcoholic fatty liver diseases
inferredcites →https://doi.org/10.4254/wjh.v7.i24.2551openalex-snapshot
Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice
inferredcites →https://doi.org/10.5152/tjg.2020.19568openalex-snapshot
Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5114053openalex-extracted
Natural Products as Modulators of Nrf2 Signaling Pathway: Potential Therapeutic Agents for Metabolic Associated Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/ddr.70142openalex-snapshot
Investigating the Effects of Curcumin on Lipid Metabolism and Cell Viability in HepG2 Cells: Potential Therapeutic Implications for Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/ptr.70302openalex-snapshot
Costunolide Ameliorates Hepatic Steatosis and Insulin Resistance in a Diet‐Induced Mouse Model of Metabolic Dysfunction‐Associated Steatotic Liver Disease by Activating the AMPK / ACC1 Signalling Pathway
inferred← citeshttps://doi.org/10.1016/j.bbrc.2024.150424openalex-snapshot
Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117989openalex-snapshot
The therapeutic role of natural compounds mediated through Nrf2 in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.cej.2026.178514openalex-snapshot
FcRn-hitchhiking BSA-galactose nanoparticles for liver-targeted delivery of astaxanthin in non-alcoholic fatty liver
inferred← citeshttps://doi.org/10.1093/bib/bbaf403openalex-snapshot
Prioritizing pathway signature using deep learning approach: a novel strategy for traditional Chinese medicine formula generation and optimization
inferred← citeshttps://doi.org/10.1111/1750-3841.17173openalex-snapshot
Transcriptome profiling reveals the protective mechanism of sulfated Cyclocarya paliurus polysaccharides against oxidative damage of IEC‐6 cell
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.